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ABSTRACT 
Aim: Gestational diabetes mellitus (GDM) is one of the most common medical disorders found in pregnancy, associated with significant 
metabolic alterations, increased maternal and perinatal morbidity and mortality. Objective was to found out the incidence, risk factor 
of GDM and outcomes in antenatal.  
Materials and Method: A prospective observational study was carried out for a period of 7 months. Total 246 pregnant women 
between 24th to 28th weeks gestation were screened for GDM by DIPSI method.  
Results: Total 10 patients were diagnosed with GDM out of 246 antenatal. The incidence of GDM was found to be 4.06 %. Risk factors 
of GDM such as age ≥25years (30%), BMI ≥25 (30%), parity ≥ 3 (30%) were showed significant correlation in study. The most common 
maternal outcome was macrosomia followed by IUGR. Approximately 98% of the women had experienced one or more complains 
during the term of pregnancy. Anaemia (98.37%) was major complain followed by  urinary tract infection 0.40% and non obstetric 
morbidities included vomiting 2.43%, pain in abdomen 9.34%, Diarrhea 1.62%, Cough 2.03% and fever 2.03%.  
Conclusion: GDM is the most common metabolic complication in pregnancy that causes fetal mortality and morbidity. Parity, age, 
Body Mass Index (BMI) shows statistically significant correlation (P<0.05) with association of GDM. Anemia was found predominant. 
KEYWORDS : Gestational Diabetes Mellitus, Incidence, Risk factor, Maternal and Fetal outcome. 
 
INTRODUCTION 
 Gestational diabetes mellitus (GDM) is a medical 
condition complicating pregnancy, and in the face of the rising 
prevalence of diabetes, particularly in women of child bearing 
age, the problem is growing [1, 2]. GDM is defined as any degree 
of carbohydrate intolerance with the first recognition or onset 
during pregnancy, irrespective of treatment with diet or insulin, 
with or without remission after the end of pregnancy [3]. 
Gestational diabetes mellitus usually presents late in the second 
or during the third trimester [4]. The prevalence of GDM varies 
from 1-16% according to the diagnosis criteria and population. 
The prevalence of GDM is more in south India when compared 
to other part of India and Southeast Asia [5]. The risk factors for 
GDM are age >30 years, family history of diabetes mellitus, 
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obesity, history of macrosomia, glycouria, previous unexplained 
neonatal death, unexplained recurrent abortion, Previous 
congenital malformations, history of hydramnios, history of 
stillbirth, history of gestational hypertension and history of pre-
eclampsia [6]. Maternal complications are Pre-eclampsia and 
cesarean delivery. Fetal complications are shoulder dystocia, 
birth injuries, neonatal hyperbilirubinaemia, hypoglycemia and 
respiratory distress syndrome [7]. 
 Many women do not die of causes related to pregnancy 
but suffer severe morbidities [8]. The world development report 
estimated that 18% of the burden of disease for these women is 
due to maternal causes [8]. The World Health Organization 
(1992) has defined obstetric morbidity as morbidity among 
women who have been pregnant (regardless of site or duration 
of the pregnancy) from any cause related to or aggravated by 
the pregnancy or its management, but not from accidental or 
incidental causes [9, 10]. Obstetric morbidity is one of the major 
causes of maternal death [8]. 
 Maternal morbidity is defined as morbidities that 
occur during pregnancy or childbirth within 42 days after giving 
birth. They can be acute, or chronic, lasting for months or even 
years. Many of these are conditions that may cause difficulty in 
pregnancy, and aggravate existing morbidities, which can lead 
to more severe consequences for women. Improving maternal 
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health is one of the eight-millennium development goals 
(MDGs). Under MDG5, countries committed to reducing 
maternal mortality by three-quarters between 1990 and 2015. 
Since 1990, maternal deaths worldwide have dropped by 47% 
[11]. 
 Review of current data suggests that, Indian women 
have the highest frequency of GDM necessitating universal 
screening. Pregnancy is more relevant as Indian women have 
11-fold increased risk of developing GDM compared to other 
places. As a result to know the risk factors and the prevalence of 
GDM in pregnant women at the rural area study is planned for 
Antenatal in Rural Anand District of Gujarat. Moreover, outline 
the common health outcome in pregnant women. India has the 
largest number of diabetes patient in the world with an 
estimated number of 46 million in women in India are in 
reproductive age are affected by diabetes. However there has 
only little data study in India on gestational diabetes mellitus. 
Hence the study was planned to find out the incidence, risk 
factors and outcomes in gestational diabetes mellitus. 
MATERIALS AND METHODS 
 A prospective observational study was conducted on 
pregnant women attending to outpatient department of 
obstetrics and gynaecology, at Community Health Centre, Sarsa 
over a period of 7 months from June 2016 to December 2016. 
Pregnant women between (24th to 28th) weeks of gestation were 
included in the study. Cases having known diabetics, or who 
were suffering from any chronic illness were excluded from the 
study. 
 All antenatal were screened for GDM by DIPSI method. 
All pregnant women were given 75 g of glucose irrespective of 
their last meal. Venous plasma glucose was estimated after 2 
hours, and cases with 2 hours plasma glucose value ≥ 140mg /dl 
were diagnosed as having GDM. All GDM patients were followed 
up and treated with medication and diet till delivery by 
specialist.  Data were analyzed and further evaluated for the 
incidence, risk factors and outcome of GDM. 
Data Collection: (For morbidity Pattern): 
 Data were collected for the period of June 2016 to 
December 2016. The data were collected directly from patients, 
family members, inpatient files and outpatient medical records, 
maternal data include age, weight, height, obstetric history, 
treatment, laboratory investigation and current diagnosis 
details were collected. 
Statistical Analysis: All statistical analysis was performed 
using the Statistical Package for the Social Science (SPSS) 
version 23. Categorical analyses were performed using 
Microsoft Excel 2007. Data are expressed as percentage. To 
assess the maternal and fetal outcomes in different group 
patient chi square test was used p value less than 0.05 was 
considered as statistically significant. 
RESULTS 
 
Gestational Diabetes Mellitus: 
 A total 246 pregnant women who attended antenatal 
clinic during the period of June 2016 to December 2016 were 
enrolled in the study. 
 
 Among 246 pregnant women, 10 (4.06%) women were 
diagnosed with gestational diabetes mellitus. 
 Out of 246 antenatal women population, the mean age 
of pregnant women was 23.8±9 (S.D 3.62) years, the highest 
number of patients 51.62% were from the age group 21-25 
years which constituted 22.76% of the study population. Out of 
which, 10 (4.06%) were diagnosed as having GDM using the 
DIPSI method. There was no statistically significant association 
between age and GDM (P > 0.05) (Table 1).  
 
 Table 2 shows parity information of patients, out of 
246 women, 170 (69.10%) women were found to have null 
parity, 52 (21.13%) patients had 2 parity, 24 cases were 
multigravida (9.75%). There was a significant correlation 
between GDM and gravida (≥3) (P=0.028). 
 
 In our study, 17 (6.91%) patient had been considered 
as overweight and 7 (2.84%) were obese women. There was no 
significant correlation between GDM and Body Mass Index 
(BMI) (P >0.05) (Table.3). 
 
 In our study, parity ≥ 3 (P = 0.028) and age ≥ 25 with 
BMI ≥ 25 kg/m2 (p = 0.023) showed statistically significant 
correlation with GDM.  Out of 10 cases of GDM, 50% (n = 5) of 
antenatal showed one or more risk factor, while remain 5 cases 
were without any risk factors shown in table.4. 
 In GDM patients, minimum birth weight observed was 
2.4 kg and the maximum birth weight observed was 4.39 kg in 
the study. Table 5 represents the mode of pregnancy outcome.
 
Table No. 1: Distribution of cases according to age and occurrence of GDM 
Age Group (Years) No. of Cases (n=246) Non GDM (n=236) GDM (n=10) Chi square test (P value) 
16-20 56(22.76%) 55(23.30%) 1(10%) 0.326 
21-25 127(51.62%) 121(51.27%) 6(60%) 0.589 
26-30 63(25.60%) 60(25.42%) 3(30%) 0.745 
 
Table No. 2: Distribution of cases according to gravida and occurrence of GDM 
Gravida No. of Cases (n=246) Non GDM (n=236) GDM (n=10) P value 
G1 170(69.10%) 165(69.91%) 5(50%) 0.182 
G2 52(21.13%) 50(21.18%) 2(20%) 0.928 
≥G3 24(9.75%) 21(8.89%) 3(30%) 0.028* 
* Significance  
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Table No. 3: Distribution of cases according to Body Mass Index (BMI) and occurrence of   GDM 
Category No. of Cases (n=246) Non GDM (n=236) GDM (n=10) P value 
≤ 23 222(90.24%) 214(90.67%) 8(80%) 0.265 
25-29.99 17(6.91%) 16(6.77%) 1(10%) 0.694 
≥ 30 7(2.84%) 6(2.54%) 1(10%) 0.165 
Table No. 4: Prevalence of risk factor in study population 
Risk factors No. of Cases (n=246) Non GDM (n=236) GDM (n=10) P value 
Age (≥ 25) 99(40.24%) 95(40.25%) 4(40%) 0.987 
Parity (≥ 3) 24(9.75%) 21(8.89%) 3(30%) 0.028* 
BMI ( ≥ 25 kg/m2) 22(8.94%) 20(8.47%) 2(20%) 0.080 
Age  ≥ 25 + parity  ≥ 3 23(9.34) 21(8.89%) 2(20%) 0.238 
Age  ≥ 25 + BMI  ≥ 25 kg/m2 12(4.87%) 10(4.23%) 2(20%) 0.023* 
 * Significance 
Table No. 5: Pregnancy outcomes in GDM cases: (N=10) 
Sr. No Pregnancy Outcome No. of patient 
1 Normal Delivery 6 
2 Caesarean section 4 
3 Macrosomia ( birth wt > 3.45Kg) 3 
4 IUGR 1 
 
Morbidity Pattern study: 
 In maternal morbidity study, out of 246 pregnant 
women who attended antenatal clinic, in which 243 (98.78%) 
women were having at least one morbidity symptoms. 
Distribution of maternal morbidity in antenatal (N=246) 
represented in figure 1. 
 In present study, total 10 types of morbidity found in 
study population during the study. Total 246 antenatal were 
visited at CHC among them 243 women had presented with at 
least one morbidity symptoms. Anaemia was found to be a top 
most morbidity in pregnant women with the prevalence of 
98.37% followed by abdominal pain 9.34% (n=23), Gestational 
Diabetes Mellitus 4.06% (n=10), vomiting 2.43% (n=6), cough 
2.03% (n=5), fever 2.03% (n=5), diarrhoea 1.62% (n=4), and 
Urinary Tract Infection 0.40% (n=1). Rural population may be a 
reason for getting high prevalence of Anaemia.  
 
 
Fig. 1: Distribution of maternal morbidity in antenatal 
Table No. 6:  Prevalence of Anaemia in the antenatal 
Sr. No Types of anemia No. of patient (n,%) Avg. Hb level  (%gm/dl) 
1 Moderate 195 (79.26%) 8.55 
2 Mild 37 (15.04%) 10.14 
3 Severe 10 (4.06%) 5.95 
4 Normal 4 (1.62%) 11.35 
5 Total 246 (100%) -- 
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Reference range: Severe anemia- ˂ 7 gm/dl, Moderate anemia- 
7-9.9 gm/dl, Mild anemia- 10-10.9 gm/dl, Normal Hb level- 11-
15 gm/dl 
 As depicted in Table.6, in present study, higher 
prevalence of anaemia found during study period. Among 246 
patients, only 4 patients had normal haemoglobin level followed 
by 79.26% (n=195) had moderate type of Anaemia, 15.04% 
(n=37) patients had mild, 4.06% (n=10) patients had severe. 
Anaemia was classified according to the WHO defined criteria. 
DISCUSSION 
 
 Gestational Diabetes Mellitus (GDM) attributes high 
risks for mother and child, mother have a GDM are led to need 
caesarean delivery due to macrosomia (≥3.45 Kg). Diabetes in 
pregnancy study group India (DIPSI) procedure of diagnosis is a 
modified version of the WHO criteria. The WHO procedure 
requires the women to be in fasting, whereas DIPSI procedure is 
performed irrespective of the last meal timing [18]. DIPSI 
procedure is a one step procedure which screens as well as and 
diagnoses GDM. It is simple, economical and feasible. To prevent 
complication in pregnancy the morbidity study is highly useful 
for reduce risk during pregnancy; it is very effective for healthy 
life for both mother & fetus. During pregnancy women suffer 
severe obstetric and non obstetric morbidities so early 
monitoring and check-up to antenatal is most effective to reduce 
mortality. 
 
Incidence: 
 In our study, incidence of GDM was found to be 4.06%. 
As per record approximately 1-14% of all pregnancies are 
diagnosed with GDM and the prevalence also keep increasing 
from year to year [16]. In present study, less incidence was found 
compare to other studies conducted by Dr. Alpana Singh, et al. 
[12], and Sedigheh Soheilykhah, et al. [13], it shows incidence rate 
5.7 % and 10.2% respectively.     
 
Risk factors: 
 Study of risk factor in GDM could be one of the useful 
tools to prevent further complication and better intervention. 
Women have age more than 25 year is being considered as 
highly risk factor for GDM. In presence study, mean average age 
of GDM patient was 23.8±9 years. In Rajesh Rajput, et al. [14], 
study found 23.62 ± 3.42 year. In our study 60% (n=6) women 
were between age 21-25 years, followed by 30% (n=2) in 26-30 
years, 10% (n=1) women between 31-35 years and 10% (n=1) 
were 16-20 years in age. Multiple studies supported the idea 
that GDM appears more frequently in pregnancy after the age 25 
because of age-related metabolic changes like increased BMI, 
hypertension and dyslipidemia and it is rare before age 20. In 
present study 40of % (n=5) GDM cases were in age group ≥25 
years. K.Ramalingam et. al. [15], study found 61.9% of GDM cases 
at same age group. 
 
 The increase in BMI is also considered as risk factor for 
GDM because considering hormonal imbalance changed 
carbohydrate regulation mechanism and insulin sensitivity. In 
our study average mean of BMI of GDM women was 24.20 ±5 
kg/m2. This finding similar to study by Sneha, et.al. [17], which 
reported 25.5 kg/m2 BMI. Our study, 30% (n=3) cases of GDM  
were had  BMI ≥ 25 kg/m2, which is in accordance with a study 
done by Binny Thomas et al. [16], showing BMI ≥ 25 kg/m2 more 
prevalent  53.60% in GDM subjects. In our study, BMI is one of 
the risk factors show significant (p= 0.023) correlation with 
GDM. 
Parity and gravida are high risk of GDM in pregnancy. In our 
study 30% GDM pregnancy had in 3 multigravida when 
compared to primigravida  50% (5). In Sneha , et al. [17], study 
found multigravida 52.1% when compared to primigravida 
41.3% [19]. In present study significant correlation (p=0.028) 
between parity and GDM was showed. 
 
Complication: 
 Chances of complication in term of outcome would be 
increased in GDM. In GDM cases the rate of caesarean section 
was high due to macrosomia. In present study 60% (n=6) of 
GDM cases were delivered vaginally while 40% (n=4) cases 
required a caesarean section, which is in agreement with a 
similar study from Archit Dahiya et al. [4], showing 60% 
spontaneous vertex deliveries, and  40% lower segment 
cesarean section (n=500) in women with GDM. 
 
 In our study macrosomia i.e. babies with birth weight 
≥3.45kg was observed in 30% (n=3) newborns of GDM mothers. 
A study conducted by Vedavathi KJ et al. [19], on Influence of 
GDM on Fetal growth parameters concluded that despite the 
attempts for good glycemic control there is a risk of macrosomia 
in GDM. 
 
 Intra uterine Growth Retardation (IUGR) is one of the 
complication in fetal outcome in GDM women in which baby 
weight was ˂ 2.5 kg. In present study one case shows IUGR baby 
while in K.Ramalingam, et al. [15], found 2 (2.8%) in fetal 
outcome in GDM women. 
 
Morbidity: 
 During study period -June 2016 to December 2016 at 
CHC total 246 antenatal were visited. Among them 243 women 
had presented with at least one morbidity symptoms. To 
evaluate maternal morbidity is highly effective to antenatal for 
maternal causes and fetus. WHO has estimated that the 
prevalence of anemia is 14% in developed and 51% in 
developing countries, where as in India it is 65-75%. Our study 
revealed a high prevalence of anemia 98.78% among pregnant 
women in rural area. 
 
 Almost all patients were uneducated and unaware of 
diet which must be taken during pregnancy to fulfill the 
nutritional support for mother and development of fetus. This 
may be one of reason for high prevalent anemic condition in 
rural population. Majority of the study population has a 
moderate degree of anemia 195 (79.26%) which Hb level range 
from (7-9.9 g/dl) followed by 37 (15.04%) had mild anemia (10-
10.9 g/dl), 10 (4.06%) had severe anemia (˂ 7 g/dl), and 4 
(1.62%) of pregnant women have normal range of hemoglobin. 
  
 In our study Obstetric morbidity like Urinary Tract 
Infection was found to be 0.40%. The common non obstetric 
morbidities present were vomiting, diarrhea, cough, fever, and 
abdominal pain etc.  
 
CONCLUSION 
 
 Gestational Diabetes Mellitus (GDM) is the most 
common metabolic complications of pregnancy, and causes fetal 
mortality and morbidity and had incidence rate 4.06% in our 
study. DIPSI guideline is most useful, cost effective procedure 
for diagnosis of GDM.  Increasing age, BMI and parity showed 
significant correlation on developing gestational diabetes 
mellitus. 
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 Anemia was found to be a top most morbidity in 
pregnant women with prevalence of 98.37% in rural population. 
Other morbidities like UTI, vomiting, diarrhea, cough, fever and 
abdominal pain were observed during study period.   
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